Erratum: Potent effects of dioscin against obesity in mice(Scientific Reports 5(7973) 10.1038/srep07973);Potent effects of dioscin against obesity in mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Min ^a   Xu, Lina ^a   Yin, Lianhong ^a   Qi, Yan ^a   Xu, Youwei ^a   Han, Xu ^a   Zhao, Yanyan ^a   Sun, Huijun ^a   Yao, Jihong ^a   Lin, Yuan ^a   Liu, Kexin ^a   Peng, Jinyong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIOSCIN; DIOSGENIN; FATTY ACID; GLUCOSE BLOOD LEVEL; TRIACYLGLYCEROL;

ANALOGS AND DERIVATIVES; ANIMAL; AUTOPHAGY; BIOSYNTHESIS; BLOOD; BODY WEIGHT; C57BL MOUSE; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INFLAMMATION; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE MUTANT; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; DIOSGENIN; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE TOLERANCE TEST; INFLAMMATION; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXIDATIVE STRESS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84929168358     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12183     Document Type: Erratum

References (58)

1. Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B., Bailey, S. M. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcoholand obesity-induced fatty liver diseases. Free Radic Biol Med 44, 1259-1272 (2008).
2. Smith, B. W.&Adams, L. A. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 48, 97-113 (2011).
3. Sanyal, A. J. et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183-1192 (2001).
4. Rolo, A. P., Teodoro, J. S., Palmeira, C. M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52, 59-69 (2012).
5. Day, C. P. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going Gut 50, 585-588 (2002).
6. Zhang, H. F. et al. Protective effects of matrine against progression of highfructose diet-induced steatohepatitis by enhancing antioxidant and antiinflammatory defences involving Nrf2 translocation. Food Chem Toxicol 55, 70-77 (2013).
7. Cohen, J. I., Roychowdhury, S., DiBello, P. M., Jacobsen, D. W., Nagy, L. E. Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49, 1709-1717 (2009).
8. Carter-Kent, C., Zein, N. N., Feldstein, A. E. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 103, 1036-1042 (2008).
9. Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., Meli, R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem 22, 699-711 (2011).
10. Homma, K., Suzuki, K., Sugawara, H. The Autophagy Database: an all-inclusive information resource on autophagy that provides nourishment for research. Nucleic Acids Res 39, D986-990 (2011).
11. Mizushima, N., Levine, B., Cuervo, A. M., Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075 (2008).
12. Sahini, N., Borlak, J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res 54, 86-112 (2014).
13. Xiong, Y. et al. Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology 276, 64-72 (2010).
14. Yang, M. Y. et al. The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J Agric Food Chem 58, 850-859 (2010).
15. Collier, J. Non-alcoholic fatty liver disease. Medicine 35, 86-88 (2007).
16. Balunas, M. J., Kinghorn, A. D. Drug discovery from medicinal plants. Life Sci 78, 431-441 (2005).
17. Chang, C. J., Tzeng, T. F., Liou, S. S., Chang, Y. S., Liu, I. M. Regulation of lipid disorders by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats. Food Chem 132, 460-467 (2012).
18. Yin, L. H. et al. An Economical method for isolation of dioscin from Dioscorea nipponica Makino by HSCCC coupled with ELSD, and a computer-aided UNIFAC mathematical model. Chromatographia 71, 15-23 (2009).
19. Hsieh, M. J., Tsai, T. L., Hsieh, Y. S., Wang, C. J., Chiou, H. L. Dioscin-induced autophagymitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines. Arch Toxicol 87, 1927-1937 (2013).
20. Li, H. et al. Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H. Wright. Fitoterapia 81, 1147-1156 (2010).
21. Li,M., Han, X.&Yu, B. Synthesis of monomethylated dioscin derivatives and their antitumor activities. Carbohydr Res 338, 117-121 (2003).
22. Lu, B. N. et al. Mechanism investigation of dioscin against CCl4-induced acute liver damage in mice. Environ Toxicol Pharmacol 34, 127-135 (2012).
23. Zhao, X. M. et al. Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxicol Lett 214, 69-80 (2012).
24. Xu, T. T. et al. Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol 88, 739-753 (2014).
25. Xu, L. N. et al. iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats. RSC Adv 4, 30704-30711 (2014).
26. Fukuda-Tsuru, S., Kakimoto, T.,Utsumi, H., Kiuchi, S.&Ishii, S. The noveldipep-tidyl peptidase-4 inhibitor teneliglipin prevents high-fat diet-inducedobesity accompanied with increased energy expenditure in mice. Eur J Pharmacol 723, 207-215 (2014).
27. Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett 580, 2917-2921 (2006).
28. Kumashiro, N. et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108, 16381-16385 (2011).
29. Fabbrini, E., Sullivan, S., Klein, S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51, 679-689 (2010).
30. Cao, K. et al. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic Biol Med 67, 396-407 (2014).
31. Coyle, J. T., Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695 (1993).
32. Takahashi, T., Morita, K., Akagi, R., Sassa, S. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11, 1545-1561 (2004).
33. McNally, S. J., Harrison, E. M., Ross, J. A., Garden, O. J., Wigmore, S. J. Curcu-min induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19, 165-172 (2007).
34. McMahon, M., Itoh, K., Yamamoto, M., Hayes, J. D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278, 21592-21600 (2003).
35. Zhao, Y., Fu, Y., Hu, J., Liu, Y., Yin, X. The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IkappaBalpha stimulated by tumour necrosis factor-alpha in cultured vascular smooth muscle cells. Arch Cardiovasc Dis 106, 4-11 (2013).
36. Mandrekar, P., Szabo, G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50, 1258-1266 (2009).
37. Gao, B., Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572-1585 (2011).
38. Houstis, N., Rosen, E. D., Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948 (2006).
39. Czaja, M. J., Liu, H.&Wang, Y. Oxidant-induced hepatocyte injury from menadi-one is regulated by ERK and AP-1 signaling. Hepatology 37, 1405-1413 (2003).
40. Sarkar, S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeu-tic application of autophagy enhancers. Biochem Soc Trans 41, 1103-1130 (2013).
41. Yang, L., Li, P., Fu, S., Calay, E. S., Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 11, 467-478 (2010).
42. Musso, G., Gambino, R., Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48, 1-26 (2009).
43. Nakajima, T. et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40, 972-980 (2004).
44. Shimano, H. et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99, 846-854 (1997).
45. Lima-Cabello, E. et al. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin Sci (Lond.) 120, 239-250 (2011).
46. Ramsay, R. R., Gandour, R. D., van der Leij, F. R. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546, 21-43 (2001).
47. Abdelmegeed, M. A. et al. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 141, 603-610 (2011).
48. Knight, B. L. et al. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. Biochem J 389, 413-421 (2005).
49. Powell, E. E., Jonsson, J. R., Clouston, A. D. Steatosis: co-factor in other liver diseases. Hepatology 42, 5-13 (2005).
50. Butler, J. A., Hagen, T. M., Moreau, R. Lipoic acid improves hypertriglyceri-demia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 485, 63-71 (2009).
51. Gnoni, G. V., Paglialonga, G., Siculella, L. Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 39, 761-768 (2009).
52. Zhang, S. et al. Effects of flavonoids from Rosa laevigata Michx fruit against highfat diet-induced non-alcoholic fatty liver disease in rats. Food Chem 141, 2108-2116 (2013).
53. Vallim, T., Salter, A. M. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot. Essent Fatty Acids 82, 211-218 (2010).
54. Martina, F., Klemen,S., Ursula, P.&Damjana, R. High-fat Medium and Circadian Transcription Factors (Cryptochrome and Clock) Contribute to the Regulationof Cholesterogenic Cyp51 and Hmgcr Genesin Mouse Embryonic Fibroblasts. Acta Chim Slov 55, 85-92 (2008).
55. Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMPactivatedprotein kinase. Nature 415, 339-343 (2002).
56. Lee, Y. M. et al. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function inmice fed high-fat diets. Nutrition 22, 956-964 (2006).
57. Yin, L. H. et al. A green and efficient protocol for industrial-scale preparation of dioscin from Dioscorea nipponica Makino by two-step macroporous resin column chromatography. Chem Eng J 165, 281-289 (2010).
58. Kim, M. et al. Anti-obesity effectsof alpha-lipoic acid mediated by suppression of hypothalamic AMP-activatedprotein kinase. Nat Med 10, 727-733 (2004).